Chemtura (CHMT) Prelim. Q2 Revs Fall In-Line with Consensus
Tweet
Share
E-mailGet Alerts CHMT Hot Sheet
Join SI Premium – FREE
Chemtura Corporation (NYSE: CHMT) announced preliminary financial operating results for the second quarter ended June 30, 2013 in conjunction with the announcement of our offering of senior notes due 2021.
Sales were around $735 million while adjusted EBITDA was $109 million in the quarter. In the same period last year, sales were $741 million with adjusted EBITDA of $118 million.
The Street consensus was looking for revs of $734.9 million and sees EPS of $0.34.
Sales were around $735 million while adjusted EBITDA was $109 million in the quarter. In the same period last year, sales were $741 million with adjusted EBITDA of $118 million.
The Street consensus was looking for revs of $734.9 million and sees EPS of $0.34.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Labcorp (LH) Tops Q1 EPS by 19c ; Offers Guidance
- Michelin misses Q1 sales estimates amid weaker volumes
Create E-mail Alert Related Categories
Guidance, Hot Corp. NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
